$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The autonomic nervous system (ANS) is a crucial part of the peripheral nervous system that maintains body homeostasis, including the adaption to environmental conditions and pathology1. It is involved in the regulation of multiple organ systems throughout the body such as the cardiovascular, respiratory, digestive, and endocrine systems. The ANS is divided into sympathetic and parasympathetic branches. Spinal branches of the sympathetic nervous system synapse in ganglia of the sympathetic chain, situated bilaterally in a paravertebral position. The bilateral cervical and thoracic ganglia, especially the StG, are important components participating in cardiac sympathetic innervation. In disease states, such as cardiac ischemia, neuronal remodeling can occur, resulting in a sympathetic overdrive2. The neuronal remodeling has been demonstrated in multiple histological studies in humans and several other animal species3,4,5,6. A detailed biological characterization of cardiac ischemia-induced neuronal remodeling in cardiac sympathetic ganglia is currently lacking, and the fundamental biological characteristics of specialized neuronal cell types or subtypes within the cardiac sympathetic nervous system (SNS) are not fully determined yet in health and disease7.
Novel technologies, such as scRNA-seq, have opened gateways for the genetic characterization of small tissues on a single-cell level8,9. However, the relatively large size of neurons may impede the optimized use of these single-cell techniques in humans10. In addition, single-cell sequencing requires a high-throughput of cells to recover a sufficient cell number due to a high loss in the sequencing process. This might prove challenging when studying small tissues that are hard to capture in one session and require multiple samples to introduce enough single cells for sequencing. The recently developed droplet-based snRNA-seq technology (i.e., the 10x Chromium platform) allows the study of biological differences among single nuclei11,12. snRNA-seq holds an advantage over scRNA-seq for large cells (>30 µm), which may not be captured in Gel Bead in Emulsions (GEMs), as well as improved compatibility with extensive dissociation and/or prolonged preservation13,14,15.
Heterogeneity, the number of neuronal cells, and other cells enriched in the cardiac SNS are important aspects for the characterization of the ANS in health and disease states. In addition, the organ- or region-specific innervation by each sympathetic ganglion contributes to the complexity of the SNS. Moreover, cervical, stellate, and thoracic ganglia of the sympathetic chain have been shown to innervate different regions of the heart16. Therefore, it is necessary to perform single-nucleus analysis of ganglionic cells derived from individual ganglia to study their biological architecture.
Droplet-based snRNA-seq allows transcriptome-wide expression profiling for a pool of thousands of cells from multiple samples at once with lower costs than plate-based sequencing platforms. This approach enables droplet-based snRNA-seq to be more suitable for cellular phenotype classification and new subpopulation identification of cells within the SCG and the StG. Notably, this protocol provides a concise stepwise approach for the identification, isolation, and single-nucleus RNA sequencing of sympathetic extrinsic cardiac ganglia, a method that has the potential for a broad application in studies of the characterization of ganglia innervating other related organs and tissues in health and disease.